| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 18 | 2010 | 33 | 0.900 |
Why?
|
| Interleukin-17 | 5 | 2011 | 101 | 0.830 |
Why?
|
| T-Lymphocytes | 12 | 2011 | 1195 | 0.700 |
Why?
|
| CD28 Antigens | 4 | 2011 | 88 | 0.690 |
Why?
|
| Thymus Gland | 11 | 2002 | 195 | 0.620 |
Why?
|
| Lymphocyte Activation | 11 | 2011 | 728 | 0.590 |
Why?
|
| Receptors, Immunologic | 3 | 2011 | 135 | 0.470 |
Why?
|
| Signal Transduction | 15 | 2011 | 3241 | 0.470 |
Why?
|
| Tenodesis | 1 | 2013 | 6 | 0.470 |
Why?
|
| Protein-Tyrosine Kinases | 14 | 1999 | 302 | 0.460 |
Why?
|
| Receptors, Interleukin-17 | 2 | 2011 | 10 | 0.420 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2009 | 2 | 0.360 |
Why?
|
| Antigens, CD | 5 | 2009 | 458 | 0.350 |
Why?
|
| CD4 Antigens | 6 | 2001 | 83 | 0.350 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 75 | 0.350 |
Why?
|
| Ubiquitin | 1 | 2009 | 93 | 0.340 |
Why?
|
| CD8 Antigens | 6 | 2001 | 82 | 0.340 |
Why?
|
| Ligands | 2 | 2009 | 433 | 0.330 |
Why?
|
| Killer Cells, Natural | 2 | 2009 | 267 | 0.310 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2004 | 645 | 0.300 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2004 | 372 | 0.300 |
Why?
|
| Mice | 32 | 2011 | 11352 | 0.300 |
Why?
|
| Shoulder Joint | 4 | 2013 | 90 | 0.290 |
Why?
|
| Milk Proteins | 3 | 2002 | 24 | 0.270 |
Why?
|
| Interleukin-7 | 3 | 2002 | 41 | 0.270 |
Why?
|
| Interleukins | 4 | 2011 | 134 | 0.270 |
Why?
|
| Mice, Transgenic | 16 | 2011 | 1540 | 0.260 |
Why?
|
| Molecular Sequence Data | 14 | 2011 | 3030 | 0.240 |
Why?
|
| Animals | 36 | 2011 | 26582 | 0.230 |
Why?
|
| Patient Positioning | 2 | 2014 | 63 | 0.230 |
Why?
|
| Cytokines | 4 | 2010 | 776 | 0.220 |
Why?
|
| Cell Differentiation | 8 | 2011 | 1458 | 0.220 |
Why?
|
| Arthroscopy | 3 | 2013 | 94 | 0.210 |
Why?
|
| Growth Inhibitors | 2 | 2011 | 41 | 0.200 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 1047 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 12 | 2011 | 3092 | 0.190 |
Why?
|
| B-Lymphocyte Subsets | 2 | 1999 | 40 | 0.180 |
Why?
|
| Biomechanical Phenomena | 2 | 2013 | 457 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2004 | 272 | 0.180 |
Why?
|
| Rotator Cuff | 2 | 2010 | 44 | 0.170 |
Why?
|
| Amino Acid Sequence | 12 | 2011 | 2062 | 0.170 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 154 | 0.170 |
Why?
|
| Calcium | 3 | 2004 | 1156 | 0.160 |
Why?
|
| Cells, Cultured | 7 | 2011 | 2818 | 0.160 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 1920 | 0.150 |
Why?
|
| Mice, Knockout | 9 | 2011 | 1924 | 0.150 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 449 | 0.140 |
Why?
|
| Anesthesia, General | 2 | 2014 | 114 | 0.130 |
Why?
|
| Cadaver | 2 | 2013 | 185 | 0.130 |
Why?
|
| Oxygen Consumption | 2 | 2014 | 239 | 0.130 |
Why?
|
| Cell Line | 7 | 2011 | 2468 | 0.130 |
Why?
|
| GATA3 Transcription Factor | 2 | 2010 | 48 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2002 | 429 | 0.110 |
Why?
|
| Anesthesia, Conduction | 1 | 2013 | 18 | 0.110 |
Why?
|
| Hematopoiesis | 2 | 1993 | 163 | 0.110 |
Why?
|
| Awards and Prizes | 1 | 2013 | 36 | 0.110 |
Why?
|
| Rotator Cuff Injuries | 2 | 2010 | 46 | 0.110 |
Why?
|
| Oximetry | 1 | 2013 | 84 | 0.110 |
Why?
|
| T-Box Domain Proteins | 2 | 2010 | 118 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2013 | 265 | 0.100 |
Why?
|
| Receptors, Interleukin-7 | 3 | 2002 | 28 | 0.100 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2011 | 23 | 0.100 |
Why?
|
| Lymphocytes | 4 | 2003 | 464 | 0.100 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 334 | 0.100 |
Why?
|
| Immunity, Mucosal | 1 | 2011 | 69 | 0.100 |
Why?
|
| Humans | 21 | 2014 | 86643 | 0.100 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2010 | 6 | 0.100 |
Why?
|
| Suture Anchors | 1 | 2010 | 5 | 0.100 |
Why?
|
| Protein Subunits | 1 | 2011 | 122 | 0.100 |
Why?
|
| Cytoplasm | 2 | 2009 | 281 | 0.100 |
Why?
|
| Cricetinae | 2 | 2011 | 560 | 0.100 |
Why?
|
| Tendons | 1 | 2010 | 44 | 0.100 |
Why?
|
| Protein Transport | 2 | 2009 | 411 | 0.090 |
Why?
|
| Enzyme Activation | 6 | 2004 | 692 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2010 | 149 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2002 | 1208 | 0.090 |
Why?
|
| Antibodies, Bispecific | 1 | 2009 | 21 | 0.090 |
Why?
|
| Th1 Cells | 1 | 2010 | 164 | 0.090 |
Why?
|
| B7 Antigens | 1 | 2009 | 5 | 0.090 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2014 | 34 | 0.090 |
Why?
|
| Pacemaker, Artificial | 1 | 2010 | 87 | 0.090 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 1993 | 17 | 0.090 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2009 | 19 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2010 | 152 | 0.090 |
Why?
|
| K562 Cells | 1 | 2009 | 43 | 0.090 |
Why?
|
| Interleukin-23 | 1 | 2009 | 54 | 0.090 |
Why?
|
| Bursa, Synovial | 1 | 2009 | 3 | 0.090 |
Why?
|
| Antigens, Surface | 1 | 2009 | 101 | 0.090 |
Why?
|
| Th2 Cells | 1 | 2010 | 146 | 0.090 |
Why?
|
| Tendon Injuries | 1 | 2009 | 37 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 241 | 0.080 |
Why?
|
| Carbon Dioxide | 2 | 2014 | 188 | 0.080 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 129 | 0.080 |
Why?
|
| Protein Engineering | 1 | 2009 | 140 | 0.080 |
Why?
|
| Transfection | 4 | 2007 | 896 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 2 | 2013 | 109 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2009 | 444 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 295 | 0.080 |
Why?
|
| Protein Binding | 4 | 2007 | 1456 | 0.080 |
Why?
|
| Interleukin-2 | 3 | 2011 | 249 | 0.080 |
Why?
|
| Binding, Competitive | 1 | 2007 | 145 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2011 | 425 | 0.080 |
Why?
|
| Receptors, Cytokine | 4 | 2011 | 28 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 557 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2009 | 579 | 0.080 |
Why?
|
| Male | 12 | 2014 | 40965 | 0.070 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 5 | 1996 | 95 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 154 | 0.070 |
Why?
|
| Tyrosine | 5 | 2002 | 133 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 797 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2010 | 425 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2007 | 201 | 0.070 |
Why?
|
| Species Specificity | 1 | 2007 | 678 | 0.070 |
Why?
|
| Flow Cytometry | 6 | 2010 | 679 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2009 | 409 | 0.070 |
Why?
|
| STAT5 Transcription Factor | 3 | 2002 | 42 | 0.070 |
Why?
|
| src-Family Kinases | 3 | 2004 | 74 | 0.060 |
Why?
|
| Apoptosis | 2 | 2004 | 1683 | 0.060 |
Why?
|
| Middle Aged | 6 | 2014 | 25028 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 3990 | 0.060 |
Why?
|
| Transgenes | 2 | 2004 | 180 | 0.060 |
Why?
|
| Dermatitis | 1 | 2004 | 32 | 0.060 |
Why?
|
| Leukemia, T-Cell | 1 | 2003 | 17 | 0.060 |
Why?
|
| Stroke | 1 | 2013 | 965 | 0.060 |
Why?
|
| Cyclins | 1 | 2003 | 82 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 2426 | 0.060 |
Why?
|
| Aged | 4 | 2014 | 18415 | 0.060 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 148 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1993 | 66 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1749 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 493 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 222 | 0.050 |
Why?
|
| Stromal Cells | 2 | 2002 | 143 | 0.050 |
Why?
|
| Female | 9 | 2014 | 44532 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 271 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2002 | 270 | 0.050 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2011 | 39 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 724 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 4 | 2004 | 24 | 0.050 |
Why?
|
| Interleukin-4 | 2 | 2010 | 127 | 0.050 |
Why?
|
| Phosphorylation | 3 | 1999 | 1106 | 0.040 |
Why?
|
| src Homology Domains | 1 | 1999 | 44 | 0.040 |
Why?
|
| Proline | 1 | 1999 | 57 | 0.040 |
Why?
|
| Janus Kinase 3 | 1 | 1999 | 9 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 927 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 1999 | 15 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 1 | 1999 | 40 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 4 | 2009 | 1376 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2010 | 248 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 57 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 1999 | 164 | 0.040 |
Why?
|
| Interferon-gamma | 2 | 2010 | 444 | 0.040 |
Why?
|
| Base Sequence | 5 | 1994 | 2330 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1998 | 67 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 101 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 1999 | 253 | 0.040 |
Why?
|
| Fetus | 1 | 1999 | 226 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1991 | 427 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2003 | 502 | 0.040 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1996 | 34 | 0.040 |
Why?
|
| CD3 Complex | 3 | 2004 | 135 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2014 | 35 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 90 | 0.030 |
Why?
|
| Gene Expression | 3 | 1994 | 1284 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2014 | 60 | 0.030 |
Why?
|
| Shoulder | 1 | 2014 | 42 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 53 | 0.030 |
Why?
|
| Kinetics | 2 | 2009 | 1513 | 0.030 |
Why?
|
| Liver | 1 | 1999 | 1230 | 0.030 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1993 | 9 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1993 | 100 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1993 | 117 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 126 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2004 | 1981 | 0.030 |
Why?
|
| Mitosis | 1 | 1993 | 153 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1993 | 102 | 0.030 |
Why?
|
| Citrobacter rodentium | 1 | 2011 | 13 | 0.030 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 13 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2011 | 49 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1991 | 0.030 |
Why?
|
| Heart Rate | 1 | 2014 | 492 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2011 | 23 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2004 | 712 | 0.020 |
Why?
|
| fas Receptor | 2 | 2004 | 75 | 0.020 |
Why?
|
| Thymoma | 1 | 1991 | 30 | 0.020 |
Why?
|
| Oncogenes | 1 | 1991 | 88 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 1041 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2010 | 4 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 1991 | 41 | 0.020 |
Why?
|
| L-Selectin | 1 | 2010 | 16 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 126 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 57 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2014 | 710 | 0.020 |
Why?
|
| Shoulder Dislocation | 1 | 2010 | 16 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 2000 | 646 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2013 | 4213 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 196 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 286 | 0.020 |
Why?
|
| Catheters | 1 | 2010 | 74 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2010 | 171 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2010 | 81 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2010 | 108 | 0.020 |
Why?
|
| Alleles | 1 | 1993 | 1128 | 0.020 |
Why?
|
| Single-Chain Antibodies | 1 | 2009 | 17 | 0.020 |
Why?
|
| Half-Life | 1 | 2009 | 96 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 38 | 0.020 |
Why?
|
| Time Factors | 1 | 1999 | 5210 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2010 | 82 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 52 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 99 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 376 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2002 | 339 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 166 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 615 | 0.020 |
Why?
|
| Sprains and Strains | 1 | 2009 | 12 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2010 | 221 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 504 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 989 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 137 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 79 | 0.020 |
Why?
|
| Hypoxia | 1 | 2014 | 641 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 1143 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1577 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 496 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 355 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2010 | 397 | 0.020 |
Why?
|
| Proteins | 1 | 1993 | 777 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2009 | 597 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1987 | 148 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1753 | 0.020 |
Why?
|
| Cell Division | 2 | 2002 | 696 | 0.020 |
Why?
|
| Peptides | 2 | 1999 | 639 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 3640 | 0.020 |
Why?
|
| Mutation | 3 | 1998 | 3968 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1991 | 1197 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 920 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 977 | 0.020 |
Why?
|
| Lectins, C-Type | 2 | 1996 | 85 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1578 | 0.020 |
Why?
|
| Receptors, Oncostatin M | 1 | 2004 | 1 | 0.020 |
Why?
|
| Spleen | 2 | 1998 | 430 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 25 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2004 | 35 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2004 | 36 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 49 | 0.020 |
Why?
|
| Cyclin D2 | 1 | 2003 | 19 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2003 | 20 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 68 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2014 | 2207 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 2003 | 1196 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2004 | 109 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2003 | 83 | 0.010 |
Why?
|
| Solubility | 1 | 2004 | 177 | 0.010 |
Why?
|
| DNA | 1 | 1989 | 1294 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2004 | 81 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2003 | 120 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 329 | 0.010 |
Why?
|
| Antigens | 1 | 2004 | 228 | 0.010 |
Why?
|
| Immunologic Capping | 1 | 2002 | 14 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2002 | 10 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 2216 | 0.010 |
Why?
|
| Protein Kinase C-theta | 1 | 2002 | 16 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2004 | 154 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 263 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2003 | 303 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2003 | 261 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2003 | 435 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 2271 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 1996 | 937 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2003 | 547 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 460 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2002 | 139 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 428 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 279 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 228 | 0.010 |
Why?
|
| Phosphotyrosine | 2 | 1991 | 32 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 689 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 381 | 0.010 |
Why?
|
| United States | 1 | 2013 | 6672 | 0.010 |
Why?
|
| Oncostatin M | 1 | 1999 | 1 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 736 | 0.010 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 1999 | 20 | 0.010 |
Why?
|
| Genes, fos | 1 | 1999 | 24 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 1999 | 77 | 0.010 |
Why?
|
| Alanine | 1 | 1999 | 85 | 0.010 |
Why?
|
| Retroviridae | 1 | 1999 | 79 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 666 | 0.010 |
Why?
|
| Ionomycin | 1 | 1998 | 21 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 1673 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1998 | 108 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 85 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1384 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 1998 | 156 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 113 | 0.010 |
Why?
|
| Lung | 1 | 2004 | 1170 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 279 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 25648 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1996 | 18 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 207 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1994 | 65 | 0.010 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1993 | 12 | 0.010 |
Why?
|
| Genes | 1 | 1994 | 305 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1993 | 46 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1992 | 229 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1994 | 623 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 39 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1991 | 332 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1991 | 177 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1994 | 1074 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 1989 | 5 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1991 | 439 | 0.010 |
Why?
|
| Cysteine | 1 | 1990 | 135 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1990 | 209 | 0.010 |
Why?
|
| Lysine | 1 | 1989 | 147 | 0.010 |
Why?
|
| Binding Sites | 1 | 1991 | 1098 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1989 | 729 | 0.000 |
Why?
|
| Melanoma | 1 | 1987 | 459 | 0.000 |
Why?
|
| Phenotype | 1 | 1989 | 2378 | 0.000 |
Why?
|